Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Common Stock | Options Exercise | +1.58K | +1.77% | 90.9K | Dec 2, 2023 | Direct | F1, F2 | ||
holding | SLDB | Common Stock | 19.4K | Dec 2, 2023 | See Footnote | F3 | |||||
holding | SLDB | Common Stock | 6.32K | Dec 2, 2023 | Wife | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Restricted Stock Units | Options Exercise | $0 | -1.58K | -100% | $0.00* | 0 | Dec 2, 2023 | Common Stock | 1.58K | Direct | F1, F5 |
Id | Content |
---|---|
F1 | Restricted stock units convert to common on a one-for-one basis. |
F2 | Represents 86,882 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. |
F3 | Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017. |
F4 | Includes 1,993 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023. |
F5 | On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full. |